Indian Company Master Data Made Simple
Alembic Pharmaceuticals Limited
Profile data last updated: 14/12/2024
Incorporated on 16 Jun 2010, Alembic Pharmaceuticals Limited has been operating for 15 years. Alembic Pharmaceuticals Limited holds the CIN L24230GJ2010PLC061123 and registration number 61123. The company is classified as company limited by shares. The company has an authorized share capital of ₹40.50 crore. Its paid up capital is ₹39.31 crore.
The firm focuses on manufacture of other chemical products. The company has been registered in the city of Ahmedabad. It is incorporated at Alembic Road, Vadodara, Vadodara, Gujarat, India, 390003. The entity is active and conducting operations. According to official records, the company’s PAN is AAICA5591M. Its LEI code is registered as 335800PM173KNG818V30. Alembic Pharmaceuticals Limited can be contacted at [email protected]. Key executives of the company are: Chirayu Ramanbhai Amin (CEO) and Rajkumar Shreeram Baheti (CFO).
Company Overview
- CIN
- Date of Incorporation
- 16/06/2010
- Company Status
- Active
- RoC
- Ahmedabad
- Registration Number
- Balance sheet date
- 31/03/2024
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- Authorized Capital
- ₹40,50,00,000.00
- Paid up Capital
- ₹39,31,26,248.00
- Activity
- Manufacture of other chemical products
- [email protected]
- PAN
Balance Sheet
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
|---|---|---|---|---|---|
| Total Non Current Liabilities Net Minority Interest | ₹17,108.00L | ₹17,238.00L | ₹17,545.00L | ₹16,795.00L | ₹0.00L |
| Accumulated Depreciation | -₹1,59,379.00L | -₹1,32,850.00L | -₹1,06,905.00L | -₹85,949.00L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹2,58,342.00L | ₹1,62,738.00L | ₹1,81,237.00L | ₹1,88,448.00L | ₹0.00L |
| Tangible Book Value | ₹5,19,094.00L | ₹4,81,820.00L | ₹4,37,046.00L | ₹5,08,273.00L | ₹0.00L |
| Long Term Provisions | ₹12,431.00L | ₹10,951.00L | ₹10,620.00L | ₹9,582.00L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹1,21,073.00L | ₹45,028.00L | ₹65,278.00L | ₹64,497.00L | ₹0.00L |
| Machinery Furniture Equipment | ₹2,62,023.00L | ₹2,41,146.00L | ₹2,06,183.00L | ₹1,42,454.00L | ₹0.00L |
| Total Assets | ₹7,77,294.00L | ₹6,44,558.00L | ₹6,18,283.00L | ₹7,12,203.00L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹5,18,952.00L | ₹4,81,820.00L | ₹4,37,046.00L | ₹5,23,755.00L | ₹0.00L |
| Gross PPE | ₹4,95,526.00L | ₹4,39,955.00L | ₹4,06,878.00L | ₹4,80,676.00L | ₹0.00L |
| Total Capitalization | ₹5,19,094.00L | ₹4,81,820.00L | ₹4,37,046.00L | ₹5,23,755.00L | ₹0.00L |
| Common Stock | ₹3,931.00L | ₹3,931.00L | ₹3,931.00L | ₹3,931.00L | ₹0.00L |
| Total Debt | ₹1,25,750.00L | ₹51,316.00L | ₹72,201.00L | ₹71,711.00L | ₹0.00L |
| Other Equity Interest | ₹5,15,163.00L | ₹1.00L | ₹4,33,116.00L | ₹5,19,824.00L | ₹0.00L |
| Other Non Current Liabilities | ₹1,892.00L | -₹1.00L | ₹2.00L | -₹1.00L | ₹0.00L |
| Capital Stock | ₹3,931.00L | ₹3,931.00L | ₹3,931.00L | ₹3,931.00L | ₹0.00L |
| Additional Paid In Capital | ₹74,839.00L | ₹74,839.00L | ₹74,839.00L | ₹79,839.00L | ₹0.00L |
| Total Non Current Assets | ₹3,68,514.00L | ₹3,36,702.00L | ₹3,27,281.00L | ₹4,26,124.00L | ₹0.00L |
| Invested Capital | ₹6,38,651.00L | ₹5,24,865.00L | ₹5,00,632.00L | ₹5,86,754.00L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹8,348.00L | ₹12,021.00L | ₹7,548.00L | ₹6,109.00L | ₹0.00L |
| Net Tangible Assets | ₹5,19,094.00L | ₹4,81,820.00L | ₹4,37,046.00L | ₹5,08,273.00L | ₹0.00L |
| Prepaid Assets | ₹29,877.00L | ₹23,277.00L | ₹22,337.00L | ₹33,486.00L | ₹0.00L |
| Cash And Cash Equivalents | ₹8,348.00L | ₹12,021.00L | ₹7,548.00L | ₹6,109.00L | ₹0.00L |
| Stockholders Equity | ₹5,19,094.00L | ₹4,81,820.00L | ₹4,37,046.00L | ₹5,23,755.00L | ₹0.00L |
| Hedging Assets Current | ₹0.00L | ₹309.00L | ₹0.00L | ₹1,457.00L | ₹0.00L |
| Other Short Term Investments | ₹1,815.00L | ₹2,713.00L | ₹1,664.00L | ₹3,162.00L | ₹0.00L |
| Share Issued | ₹1,965.63L | ₹1,965.63L | ₹1,965.63L | ₹1,965.63L | ₹0.00L |
| Current Assets | ₹4,08,779.00L | ₹3,07,856.00L | ₹2,91,002.00L | ₹2,86,079.00L | ₹0.00L |
| Working Capital | ₹1,67,545.00L | ₹1,62,356.00L | ₹1,27,310.00L | ₹1,14,426.00L | ₹0.00L |
| Net Debt | ₹1,11,209.00L | ₹31,024.00L | ₹56,038.00L | ₹56,890.00L | ₹0.00L |
| Current Debt | ₹1,19,557.00L | ₹43,045.00L | ₹63,586.00L | ₹62,999.00L | ₹0.00L |
| Ordinary Shares Number | ₹1,965.63L | ₹1,965.63L | ₹1,965.63L | ₹1,965.63L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹4,677.00L | ₹6,288.00L | ₹6,923.00L | ₹7,214.00L | ₹0.00L |
| Current Liabilities | ₹2,41,234.00L | ₹1,45,500.00L | ₹1,63,692.00L | ₹1,71,653.00L | ₹0.00L |
| Retained Earnings | ₹4,39,422.00L | ₹4,02,701.00L | ₹3,56,844.00L | ₹2,55,439.00L | ₹0.00L |
| Net PPE | ₹3,36,147.00L | ₹3,07,105.00L | ₹2,99,973.00L | ₹3,94,727.00L | ₹0.00L |
| Construction In Progress | ₹83,723.00L | ₹52,436.00L | ₹60,128.00L | ₹2,20,579.00L | ₹0.00L |
| Other Non Current Assets | -₹72.00L | ₹3,330.00L | ₹5,374.00L | -₹2.00L | ₹0.00L |
| Common Stock Equity | ₹5,19,094.00L | ₹4,81,820.00L | ₹4,37,046.00L | ₹5,23,755.00L | ₹0.00L |
| Other Properties | ₹44,507.00L | ₹43,722.00L | ₹43,423.00L | ₹40,452.00L | ₹0.00L |
| Inventory | ₹2,28,814.00L | ₹1,64,354.00L | ₹1,47,527.00L | ₹1,60,970.00L | ₹0.00L |
Cash Flow
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
|---|---|---|---|---|---|
| Changes In Cash | -₹3,673.00L | ₹4,472.00L | ₹1,440.00L | -₹3,697.00L | ₹0.00L |
| Financing Cash Flow | ₹44,371.00L | -₹43,787.00L | -₹26,196.00L | -₹21,735.00L | ₹0.00L |
| Net Income | ₹58,342.00L | ₹61,582.00L | ₹34,199.00L | ₹54,568.00L | ₹0.00L |
| Investing Cash Flow | -₹56,841.00L | -₹32,061.00L | -₹44,759.00L | -₹37,197.00L | ₹0.00L |
| Free Cash Flow | -₹47,565.00L | ₹47,573.00L | ₹28,054.00L | ₹12,671.00L | ₹0.00L |
| End Cash Position | ₹8,348.00L | ₹12,021.00L | ₹7,548.00L | ₹6,109.00L | ₹0.00L |
| Capital Expenditure | -₹56,362.00L | -₹32,747.00L | -₹44,341.00L | -₹42,564.00L | ₹0.00L |
| Beginning Cash Position | ₹12,021.00L | ₹7,548.00L | ₹6,109.00L | ₹9,806.00L | ₹0.00L |
| Operating Cash Flow | ₹8,797.00L | ₹80,320.00L | ₹72,395.00L | ₹55,235.00L | ₹0.00L |
Income Statement
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
|---|---|---|---|---|---|
| Income Tax Expense | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Operating Expenses | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income From Continuing Operation Net Minority Interest | ₹58,342.00L | ₹61,582.00L | ₹34,199.00L | ₹52,094.00L | ₹0.00L |
| EBITDA | ₹1,06,453.00L | ₹96,069.00L | ₹68,019.00L | ₹92,990.00L | ₹0.00L |
| Basic EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Expenses | ₹5,80,467.00L | ₹5,44,857.00L | ₹5,05,569.00L | ₹4,63,881.00L | ₹0.00L |
| Operating Revenue | ₹6,53,971.00L | ₹6,11,211.00L | ₹5,49,977.00L | ₹5,23,179.00L | ₹0.00L |
| Total Unusual Items | ₹1,279.00L | ₹521.00L | -₹892.00L | -₹136.00L | ₹0.00L |
| Ebit | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Tax Effect Of Unusual Items | ₹226.38L | ₹13.19L | -₹31.72L | -₹22.72L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | ₹1,279.00L | ₹521.00L | -₹892.00L | -₹136.00L | ₹0.00L |
| Interest Income Non Operating | ₹596.00L | ₹209.00L | ₹33.00L | ₹173.00L | ₹0.00L |
| Interest Expense Non Operating | ₹7,877.00L | ₹5,619.00L | ₹5,017.00L | ₹1,773.00L | ₹0.00L |
| Interest Income | ₹596.00L | ₹209.00L | ₹33.00L | ₹173.00L | ₹0.00L |
| Net Income From Continuing And Discontinued Operation | ₹58,342.00L | ₹61,582.00L | ₹34,199.00L | ₹52,094.00L | ₹0.00L |
| General And Administrative Expense | ₹28,046.00L | ₹25,197.00L | ₹24,105.00L | ₹21,098.00L | ₹0.00L |
| Reconciled Depreciation | ₹27,858.00L | ₹27,267.00L | ₹27,543.00L | ₹28,678.00L | ₹0.00L |
| Net Income Continuous Operations | ₹58,201.00L | ₹61,583.00L | ₹34,198.00L | ₹52,093.00L | ₹0.00L |
| Reconciled Cost Of Revenue | ₹2,13,691.00L | ₹2,00,070.00L | ₹2,02,316.00L | ₹1,72,319.00L | ₹0.00L |
| Net Income | ₹58,342.00L | ₹61,582.00L | ₹34,199.00L | ₹52,094.00L | ₹0.00L |
| Operating Income | ₹73,504.00L | ₹66,354.00L | ₹44,408.00L | ₹59,298.00L | ₹0.00L |
| Diluted Average Shares | ₹1,965.63L | ₹1,965.63L | ₹1,965.63L | ₹1,965.63L | ₹0.00L |
| Selling And Marketing Expense | ₹1,06,486.00L | ₹99,688.00L | ₹95,230.00L | ₹89,038.00L | ₹0.00L |
| Normalized Income | ₹57,289.38L | ₹61,074.19L | ₹35,059.28L | ₹52,207.28L | ₹0.00L |
| Net Non Operating Interest Income Expense | -₹7,281.00L | -₹5,410.00L | -₹4,984.00L | -₹1,600.00L | ₹0.00L |
| EBIT | ₹78,595.00L | ₹68,802.00L | ₹40,476.00L | ₹64,312.00L | ₹0.00L |
| Gross Profit | ₹4,40,280.00L | ₹4,11,141.00L | ₹3,47,661.00L | ₹3,50,860.00L | ₹0.00L |
| Cost Of Revenue | ₹2,13,691.00L | ₹2,00,070.00L | ₹2,02,316.00L | ₹1,72,319.00L | ₹0.00L |
| Diluted NIAvailto Com Stockholders | ₹58,342.00L | ₹61,582.00L | ₹34,199.00L | ₹52,094.00L | ₹0.00L |
| Net Interest Income | -₹7,281.00L | -₹5,410.00L | -₹4,984.00L | -₹1,600.00L | ₹0.00L |
| Operating Expense | ₹3,66,776.00L | ₹3,44,787.00L | ₹3,03,253.00L | ₹2,91,562.00L | ₹0.00L |
| Normalized EBITDA | ₹1,05,174.00L | ₹95,548.00L | ₹68,911.00L | ₹93,126.00L | ₹0.00L |
| Net Income Common Stockholders | ₹58,342.00L | ₹61,582.00L | ₹34,199.00L | ₹52,094.00L | ₹0.00L |
| Pretax Income | ₹70,718.00L | ₹63,183.00L | ₹35,459.00L | ₹62,539.00L | ₹0.00L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Revenue | ₹6,53,971.00L | ₹6,11,211.00L | ₹5,49,977.00L | ₹5,23,179.00L | ₹0.00L |
| Selling General And Administration | ₹1,34,532.00L | ₹1,24,885.00L | ₹1,19,335.00L | ₹1,10,136.00L | ₹0.00L |
| Other Operating Expenses | ₹60,429.00L | ₹57,559.00L | ₹51,840.00L | ₹41,788.00L | ₹0.00L |
| Diluted EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Interest Expense | ₹7,877.00L | ₹5,619.00L | ₹5,017.00L | ₹1,773.00L | ₹0.00L |
| Basic Average Shares | ₹1,965.63L | ₹1,965.63L | ₹1,965.63L | ₹1,965.63L | ₹0.00L |
| Net Income Including Noncontrolling Interests | ₹58,201.00L | ₹61,582.00L | ₹34,199.00L | ₹52,094.00L | ₹0.00L |
| Tax Provision | ₹12,517.00L | ₹1,600.00L | ₹1,261.00L | ₹10,446.00L | ₹0.00L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 16/06/2010 | Chirayu Ramanbhai Amin | 00242549 | Whole-time director | View other directorships |
| 16/06/2010 | Rajkumar Shreeram Baheti | 00332079 | Whole-time director | View other directorships |
| 31/03/2011 | Pranav Chirayu Amin | 00245099 | Managing Director | View other directorships |
| 02/05/2013 | Shaunak Chirayu Amin | 00245523 | Managing Director | View other directorships |
| 28/07/2014 | Rajkumar Shreeram Baheti | *****2161K | CFO | |
| 04/02/2015 | Archana Niranjan Hingorani | 00028037 | Director | View other directorships |
| 27/04/2016 | Chirayu Ramanbhai Amin | *****5729P | CEO | |
| 10/02/2022 | Ashok Kumar Barat | 00492930 | Director | View other directorships |
| 01/04/2023 | Manisha Saraf | *****2967L | Company Secretary | |
| 05/05/2023 | Jai Shishir Diwanji | 00910410 | Director | View other directorships |
| 31/03/2024 | Manish Santoshkumar Kejriwal | 00040055 | Director | View other directorships |
Latest Documents
Category:
| Date | Title | Size |
|---|---|---|
| 11/09/2024 | Form AOC-4(XBRL)-14082024 | - |
| 11/09/2024 | Form MGT-7-31082024 | - |
| 28/03/2024 | Form Addendum to AOC-4 CSR-28032024_signed | - |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Dabur India Limited | L24230DL1975PLC007908 | 8/3 Asaf Ali Road, New Delhi, Delhi, India, 110002 |
| Denis Chem Lab Limited | L24230GJ1980PLC003843 | Block No 457chhatral, Kalol, Gujarat, India, 382729 |
| Ind Swift Limited | L24230CH1986PLC006897 | 781industrial Area Phase Ii, Chandigarh, Chandigarh, India, 160002 |
| Lyka Labs Limited | L24230GJ1976PLC008738 | 4801/b & 4802/a Gidc Indutrail Estate, Ankleshwar, Gujarat, India, 393002 |
| Torrent Pharmaceuticals Ltd | L24230GJ1972PLC002126 | Torrent Houseoff Ashram Road Navarangpura 9, Ahmedabad, Gujarat, India, 000000 |
Address
Alembic Road, Vadodara, Vadodara, Gujarat, India, 390003
Frequently Asked Questions
What is the incorporation date of Alembic Pharmaceuticals Limited?
The incorporation date of Alembic Pharmaceuticals Limited is 16/06/2010.
What is the authorized share capital and paid-up capital of Alembic Pharmaceuticals Limited?
The authorized share capital of Alembic Pharmaceuticals Limited is ₹40,50,00,000.00. The paid-up capital is ₹39,31,26,248.00.
Who are the current board members & directors of Alembic Pharmaceuticals Limited?
The current board member of Alembic Pharmaceuticals Limited are:
- Archana Niranjan Hingorani
- Chirayu Ramanbhai Amin
- Archana Niranjan Hingorani
- Chirayu Ramanbhai Amin
- Pranav Chirayu Amin
- Shaunak Chirayu Amin
- Rajkumar Shreeram Baheti
- Ashok Kumar Barat
- Manish Santoshkumar Kejriwal
- Jai Shishir Diwanji
What is the registered address of Alembic Pharmaceuticals Limited?
The registered address of Alembic Pharmaceuticals Limited is Alembic Road, Vadodara, Vadodara, Gujarat, India, 390003.
What is the Corporate Identification Number of Alembic Pharmaceuticals Limited?
The Corporate Identification Number of Alembic Pharmaceuticals Limited is L24230GJ2010PLC061123.